Association of frailty with clinical outcomes in chronic obstructive pulmonary disease: A retrospective longitudinal cohort study

慢性阻塞性肺疾病患者虚弱与临床结局的关联:一项回顾性纵向队列研究

阅读:1

Abstract

BACKGROUND: Frailty is a clinical syndrome and common phenomenon in the elderly, particularly when it coexists with chronic obstructive pulmonary disease (COPD). However, the relationship between frailty and its prognosis in COPD patients has not been clearly elucidated. METHODS: We collected electronic data of inpatients who were diagnosed with COPD in the First Affiliated Hospital with Nanjing Medical University (NJMU) from January 2018 to December 2020. In further, we divided them into different groups based on Frailty Index Common Laboratory Tests (FI-LAB). Binary logistic regression was performed to analyze the risk factors associated with COPD. The receiver operating characteristic (ROC) curve and area under the curve (AUC) were applied to validate FI-LAB's value in prognosis. Primary clinical outcomes contained 30-day mortality and readmission. Moreover, we also compared the prognositic value of FI-LAB with Hospital Frailty Risk Score (HRS) by ROC curve, significance was set at P < 0·05. FINDINGS: The final study included 826 COPD patients, among of them, 30-day mortality and readmission of frailty group was 11·2%, 25·9%, the robust group was 4·3%, 16·0%, and p value was 0·001, 0·004 respectively. Multivariate analysis revealed that smoking, CCI≥3, oral drug≥5, pneumonia, abnormal lymphocyte, abnormal haemoglobin were independent risk factors with frailty. As for the prediction of FI-LAB about frailty in 30-day mortality, the AUC was 0·832, and 30-day readmission was 0·661. As for the prognositic value, FI-LAB and HRS showed no difference in predicting clinical outcomes. INTERPRETATION: COPD individuals have a higher rate of frailty and pre-frailty. There exists a strong correlation between frailty and 30-day mortality in COPD patients, and FI-LAB has good prognostic value in clinical outcomes of patients with COPD.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。